STRM vs. CNGL, CREX, ARBB, VRME, EBIXQ, SLE, OMQS, HCTI, KBNT, and TZOO
Should you be buying Streamline Health Solutions stock or one of its competitors? The main competitors of Streamline Health Solutions include Canna-Global Acquisition (CNGL), Creative Realities (CREX), ARB IOT Group (ARBB), VerifyMe (VRME), Ebix (EBIXQ), Super League Enterprise (SLE), OMNIQ (OMQS), Healthcare Triangle (HCTI), Kubient (KBNT), and Travelzoo (TZOO).
Streamline Health Solutions (NASDAQ:STRM) and Canna-Global Acquisition (NASDAQ:CNGL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
31.7% of Streamline Health Solutions shares are held by institutional investors. Comparatively, 19.6% of Canna-Global Acquisition shares are held by institutional investors. 29.5% of Streamline Health Solutions shares are held by insiders. Comparatively, 72.1% of Canna-Global Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Streamline Health Solutions received 224 more outperform votes than Canna-Global Acquisition when rated by MarketBeat users.
Streamline Health Solutions has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, Canna-Global Acquisition has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500.
Canna-Global Acquisition has a net margin of 0.00% compared to Streamline Health Solutions' net margin of -82.75%. Canna-Global Acquisition's return on equity of 0.00% beat Streamline Health Solutions' return on equity.
In the previous week, Streamline Health Solutions had 2 more articles in the media than Canna-Global Acquisition. MarketBeat recorded 2 mentions for Streamline Health Solutions and 0 mentions for Canna-Global Acquisition. Streamline Health Solutions' average media sentiment score of 0.22 beat Canna-Global Acquisition's score of 0.00 indicating that Streamline Health Solutions is being referred to more favorably in the media.
Canna-Global Acquisition has lower revenue, but higher earnings than Streamline Health Solutions.
Streamline Health Solutions presently has a consensus price target of $2.00, indicating a potential upside of 334.78%. Given Streamline Health Solutions' higher probable upside, equities research analysts clearly believe Streamline Health Solutions is more favorable than Canna-Global Acquisition.
Summary
Streamline Health Solutions beats Canna-Global Acquisition on 7 of the 11 factors compared between the two stocks.
Get Streamline Health Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Streamline Health Solutions Competitors List
Related Companies and Tools
